It takes immense effort for medical device and pharmaceutical products to get through development and into the marketplace to begin improving lives. In this highly regulated industry, life sciences companies must overcome a variety of challenges. Early development stage companies face a long and capital intensive process of getting their devices and/or drugs approved, many times investing billions in sophisticated private investor capital for research and development before a device or drug is even available on the market. The level of financial reporting needs to match the level of sophistication of the funding source. Mature companies must live by exacting standards to protect the public they serve.
At Weaver, we assist life sciences companies with a better understanding of the business and the risks they face. These companies rely on us for traditional assurance, tax and advisory services as well as assistance with identifying, understanding and managing risks in the achievement of strategic objectives.
Our services include:
- Assurance Services: Audit/Review/Compilation, Agreed-Upon Procedures, Employee Benefit Plan, IFRS Assessment and Conversion, Public Company, SOC Reporting
Advisory Services: Anticorruption & Compliance, CFO Advisory, ESG Reporting, Forensics & Litigation, Green Business, IT Advisory, Public Company, Restructuring & Turnaround, Risk Advisory, Transaction Advisory, Valuation
In addition to these core services, we offer a breadth of support for life sciences companies with national and international operations. Some of these services include:
Early on in the pandemic, IT departments deployed tens, hundreds or even thousands of new worksites, often in a matter of days. Read More
As managers look for ways to increase performance, we turn to the operations and ask where can we add more value and drive greater efficiencies. Read More